 |
|
Protein key to control, growth of blood cells
August 14, 2008Findings may aid in bone marrow transplants, blood diseases
New research sheds light on the biological events by which stem cells in the bone marrow develop into the broad variety of cells that circulate in the blood. The findings may help improve the success of bone marrow transplants and may lead to better treatments for life-threatening blood diseases.
"As we better understand the biological pathways that regulate the growth of stem cells, we may identify new approaches for treating blood disorders," said study leader Wei Tong, Ph.D., a hematology researcher at The Children's Hospital of Philadelphia. Her study appeared online July 10 in the Journal of Clinical Investigation.
Hematopoietic stem cells (HSCs) develop into all types of blood cells: red blood cells, platelets and immune cells. HSCs, like other stem cells, have the ability to self-renew: each can give rise to more mature, developed cells with more specific functions, as well as a new stem cell. (Everyone carries HSCs in their bone marrow, unlike embryonic stem cells, which exist only in embryos.)
In her study, conducted in mice, Tong focused on a protein called Lnk that helps control HSC expansion. When a growth factor in the blood called thrombopoietin (TPO) acts on its cell receptor, it triggers signals along a pathway that includes another protein, JAK2. JAK2, in turn, causes stem cells to increase their numbers.
Tong's group and others previously found that Lnk is a negative regulator for HSCs, acting as a brake on stem cell expansion. In the current study, they found that mice genetically engineered to lack the Lnk protein had 10 times the normal amount of HSCs in their bone marrow. Without Lnk to directly interact with JAK2 and inhibit its activity, TPO made stem cell production go into overdrive.
However, there was an unexpected potential benefit-- the expanded population of stem cells had a higher proportion of quiescent cells, those in a resting stage in the cell cycle. Quiescent stem cells, said Tong, are more likely to succeed in a recipient when they are used in bone marrow transplantation.
Although much research remains to be done, added Tong, other researchers might build on this knowledge to manipulate HSCs for more effective bone marrow transplants for cancer patients after high-dose chemotherapy or radiotherapy. It might also improve treatments for particular blood disorders. For example, aplastic anemia, severe combined immunodeficiency disorders and hemoglobin disorders involve deficiencies of specific immune cells in the blood. Using a drug to inhibit Lnk could potentially produce larger numbers of HSCs for a successful bone marrow transplant.
Myeloproliferative disorders (MPDs), on the other hand, entail the opposite danger-a sometimes-fatal overproduction of certain bone marrow cells. Clinicians might use Tong's research on Lnk and its associated signaling pathway to curtail stem cell production and control MPDs.
Children's Hospital of Philadelphia
Hematopoietic stem cells (HSCs) develop into all types of blood cells: red blood cells, platelets and immune cells. HSCs, like other stem cells, have the ability to self-renew: each can give rise to more mature, developed cells with more specific functions, as well as a new stem cell. (Everyone carries HSCs in their bone marrow, unlike embryonic stem cells, which exist only in embryos.)
In her study, conducted in mice, Tong focused on a protein called Lnk that helps control HSC expansion. When a growth factor in the blood called thrombopoietin (TPO) acts on its cell receptor, it triggers signals along a pathway that includes another protein, JAK2. JAK2, in turn, causes stem cells to increase their numbers.
Tong's group and others previously found that Lnk is a negative regulator for HSCs, acting as a brake on stem cell expansion. In the current study, they found that mice genetically engineered to lack the Lnk protein had 10 times the normal amount of HSCs in their bone marrow. Without Lnk to directly interact with JAK2 and inhibit its activity, TPO made stem cell production go into overdrive.
However, there was an unexpected potential benefit-- the expanded population of stem cells had a higher proportion of quiescent cells, those in a resting stage in the cell cycle. Quiescent stem cells, said Tong, are more likely to succeed in a recipient when they are used in bone marrow transplantation.
Although much research remains to be done, added Tong, other researchers might build on this knowledge to manipulate HSCs for more effective bone marrow transplants for cancer patients after high-dose chemotherapy or radiotherapy. It might also improve treatments for particular blood disorders. For example, aplastic anemia, severe combined immunodeficiency disorders and hemoglobin disorders involve deficiencies of specific immune cells in the blood. Using a drug to inhibit Lnk could potentially produce larger numbers of HSCs for a successful bone marrow transplant.
Myeloproliferative disorders (MPDs), on the other hand, entail the opposite danger-a sometimes-fatal overproduction of certain bone marrow cells. Clinicians might use Tong's research on Lnk and its associated signaling pathway to curtail stem cell production and control MPDs.
Children's Hospital of Philadelphia
Bone Marrow Current Events and Bone Marrow News RSSAdult stem cell breakthrough
The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.
First trachea transplant without immunosuppression
After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems. The young Colombian woman suffered from a cough that took a long time to be diagnosed as tuberculosis.
First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure.
UNC researchers find clue to stopping breast-cancer metastasis
If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine takes a step in that direction.
Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord
Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord.
Mayo Clinic Researchers Find Predictive Tests and Early Treatment Delay Progression of Blood Cell Cancer
Mayo Clinic researchers say they have moved closer to their goal of providing personalized care for a common blood cell cancer.
Children's Hospital study demonstrates how bone marrow transplant can cure sickle cell disease
A unique approach to bone marrow transplantation pioneered in part by a Children's Hospital of Pittsburgh of UPMC physician has proven to be the only safe and effective cure for sickle cell disease, according to a new study.
Washington University scientists first to sequence genome of cancer patient
For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots.
Simple chemical procedure augments therapeutic potential of stem cells
Adult stem cells resemble couch potatoes if they hang out and divide in a dish for too long. They get fat and lose key surface proteins, which interferes with their movement and reduces their therapeutic potential. Now, via a simple chemical procedure, researchers have found a way to get these cells off the couch and over to their therapeutic target.
Syracuse University researchers discover new way to attack some forms of leukemia
Each year, some 29,000 adults and 2,000 children are diagnosed with leukemia, a form of cancer that is caused by the abnormal production of white blood cells in the bone marrow.
More Bone Marrow Current Events and Bone Marrow News Articles
 | Bone Marrow Immunohistochemistry by Emina Emilia Torlakovic, Kikkeri N Naresh, Richard D Brunning Bone Marrow IHC provides a rich collection of color illustrations that demonstrate the diagnostic features of antibodies applicable to bone marrow tissue. Each of the antibodies illustrated in the volume includes a systematic description that details an expected reaction profile in both normal bone marrow cells and neoplastic cells, as well as authoritative advice about avoiding potential... |
 | Bone Marrow Pathology by Barbara J. Bain, David M. Clark, Irvin A. Lampert, Bridget S. Wilkins Written by one of the world's leading haematologists, and three renowned histopathologists, Bone Marrow Pathology provides a comprehensive guide to the diagnosis of bone marrow disease. Now in its Third Edition, the text has been extensively revised and rewritten to reflect the latest advances in the field. Features:An extremely practical, up-to-the-minute text incorporating the new WHO... |
 | Bone Marrow and Blood Stem Cell Transplants: A Guide For Patients by Susan Stewart Bone Marrow and Stem Cell Transplants: A Guide for Patients is the next generation of Susan K. Stewart's groundbreaking 1992 book Bone Marrow Transplants: A Book of Basics for Patients. This new 228 paage guide combines solid medical information with the voices of people who have been through a transplant. Comprehensive and easy-to-read, Bone Marrow and Blood Stem Cell Transplants: A Guide for... |
 | Pediatric Bone Marrow by Lila Penchansky No other book covers as extensively the pathology of the bone marrow in children. It provides a wide background for the understanding of bone marrow disease in children and its difference from that of the adult population. It illustrates the morphology of the peripheral blood, bone marrow aspirate and bone marrow biopsy. It is useful for the diagnosis of pediatric disorders in the bone marrow as... |
 | Bone Marrow and Stem Cell Transplantation (Methods in Molecular Medicine) This volume is a compendium of cutting-edge molecular methods for the successful transplantation of hematopoietic stem cells. The availability of genetic profiles for committed and uncommitted stem cells combined with the determination of molecular steps involved in hematopoietic stem cell activation and self-renewal hold tremendous promise for future success in the clinic. Currently, stem cells... |
 | On Call in Bone Marrow Transplantation (On Call in) |
 | Blood and Marrow Stem Cell Transplantation, Second Edition (Jones and Bartlett Series in Oncology) In the few years since the first edition, there have been immense changes in the number of patients receiving marrow transplants, in the number of institutions doing marrow transplants and in the number of scientific publications about marrow transplants and related fields. This new edition reflects these changes and incorporates the most current resources and information to this... |
 | Bone Marrow Transplantation (Vademecum) The unique, compact, pocket-sized format of Bone Marrow Transplantation makes this text a practical. ready-reference for house officers, fellows, nurses and pharmacists on the bone marrow transplant unit. Topics covered include: Diseases requiring bone marrow transplants, such as multiple myeloma, lymphomas, pediatric malignancies and adult solid tumors; indications, complications, drug... |
 | Bone Marrow Nei Kung: Taoist Techniques for Rejuvenating the Blood and Bone by Mantak Chia A guide to nourishing the body through bone marrow rejuvenation exercises • Presents exercises to “regrow” bone marrow, revive the internal organs, and prevent osteoporosis • Explains the use of bone breathing and bone compression, “hitting” to detoxify the body, and sexual energy massage and chi weight lifting to enhance the life force within Most Westerners believe that a daily... |
 | Atlas of Bone Marrow and Blood Pathology: A Volume in the Atlases in Diagnostic Surgical Pathology Series (Atlases in Diagnostic Surgical Pathology) by Faramarz Naeim This lavishly illustrated atlas captures the latest knowledge about bone marrow and blood pathology. The text and images work to sharpen readers' diagnostic and classification skills through a multidisciplinary approach, emphasizing morphology. Seventeen chapters cover all aspects of hematologic pathology including basic science, premalignant and malignant conditions, bone marrow hypoplasia and... |
| © 2008 BrightSurf.com |